NSVAX | VISVX | NSVAX / VISVX | |
Total Expense Ratio | 0.96 | 0.19 | 505% |
Annual Report Gross Expense Ratio | 1.11 | 0.19 | 584% |
Fund Existence | 23 years | 27 years | - |
Gain YTD | -13.908 | -10.946 | 127% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 764M | 53.6B | 1% |
Annual Yield % from dividends | 1.88 | 2.14 | 88% |
Returns for 1 year | -25.86 | -3.13 | 825% |
Returns for 3 years | -28.95 | 4.70 | -617% |
Returns for 5 years | 23.35 | 92.39 | 25% |
Returns for 10 years | -28.92 | 68.31 | -42% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SPY | 546.69 | 11.27 | +2.10% |
SPDR® S&P 500® ETF | |||
VFQY | 130.28 | 2.39 | +1.87% |
Vanguard US Quality Factor ETF | |||
BSVO | 18.40 | 0.33 | +1.83% |
EA Bridgeway Omni Small-Cap Value ETF | |||
BTA | 9.11 | 0.15 | +1.67% |
Blackrock Long-Term Municipal Advantage Trust | |||
EWUS | 36.44 | 0.58 | +1.61% |
iShares MSCI United Kingdom Small-Cp ETF |